KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Medicine and Oncology / 2021 / Cilt: 5 - Sayı: 2

Patients with Lung Cancer Followed by Breast CancerHave a Better Prognosis than Patients with these Cancersin the Opposite Order due to Differences in PathologicalComponents

Li ZHANG
Ding Yuan WANG
Yang WANG
Jing MA
Yipeng WANG
Bailin ZHANG
Sayfa
187–194
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Theproportion of small cell lung carcinoma in LFB was 4%, which was significantly lower than that in BFL (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: To explore the prognostic differences between lung cancer followed by breast cancer (LFB) and breastcancer followed by lung cancer (BFL) and the reasons for the differences.
📊
Temel Bulgular & Veri:Methods: The database we chose was SEER 18 Regs, from which we retrieved data from patients diagnosed with mul tiple primary standardized incidence rate (MP-SIR) segments of cancer.
💡
Sonuç & Katkı:Theproportion of small cell lung carcinoma in LFB was 4%, which was significantly lower than that in BFL (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: To explore the prognostic differences between lung cancer followed by breast cancer (LFB) and breastcancer followed by lung cancer (BFL) and the reasons for the differences. Methods: The database we chose was SEER 18 Regs, from which we retrieved data from patients diagnosed with mul tiple primary standardized incidence rate (MP-SIR) segments of cancer. Results: A total of 7169 patients were included, of whom 979 were patients with LFB and 6190 were BFL patients. Theproportion of small cell lung carcinoma in LFB was 4%, which was significantly lower than that in BFL (p

🔖

Bu Makaleye Atıf Yap

ZHANG, L., WANG, D. Y., WANG, Y., MA, J., WANG, Y., ZHANG, B. (2022). Patients with Lung Cancer Followed by Breast CancerHave a Better Prognosis than Patients with these Cancersin the Opposite Order due to Differences in PathologicalComponents. Eurasian Journal of Medicine and Oncology, Cilt: 5 - Sayı: 2, 187–194. https://ajindex.com/articles/509510

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Shapiro CL. Cancer Survivorship. N Engl J Med 2018;379:2438– 50
  2. Feller L, Lemmer J. New 'second primary' cancers. SADJ 2012;67:175–8
  3. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363–85
  4. Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 2011;12:353–60
  5. Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016;122:3075–86
  6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424
  7. Molina-Montes E, Requena M, Sánchez-Cantalejo E, Fernández MF, Arroyo-Morales M, Espín J, et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol 2015;136:158–71
  8. Kim BK, Oh SJ, Song JY, Lee HB, Park MH, Jung Y, et al; Korean Breast Cancer Society. Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients. J Breast Cancer 2018;21:62–9
  9. Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. II. Tumors of different tissues or organs. Cancer 1961;14:231–7
  10. Lv M, Zhang X, Shen Y, Wang F, Yang J, Wang B, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore) 2017;96:e6799
  11. Powell S, Tarchand G, Rector T, Klein M. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry. Cancer Causes Control 2013;24:1565–73
  12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34
  13. Wei JL, Jiang YZ, Shao ZM. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study. Int J Clin Onco 2019;24:934–40
  14. Deng L, Harðardottír H, Song H, Xiao Z, Jiang C, Wang Q, et al. Mortality of lung cancer as a second primary malignancy: A population-based cohort study. Cancer Med 2019;8:3269–77
  15. Kinova S, Duris I. Carcinoid tumor. Bratisl Lek Listy 2001;102:495–504. 16.